Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function
Clinical trial NCT03417778 · COMPLETED
Trial details
- NCT number
- NCT03417778
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-03
- Primary completion
- 2018-08-09
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.